BCG and Plasma Amyloid in Non-Demented Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

December 4, 2021

Study Completion Date

December 5, 2021

Conditions

Alzheimer Disease, Late Onset

Interventions

BIOLOGICAL

Bacillus of Calmette and Guerin (BCG)

Prime and boost vaccination

Trial Locations (1)

Mindful Diagnostics and Therapeutics, Eau Claire

All Listed Sponsors

lead

Mindful Diagnostics and Therapeutics, LLC

INDUSTRY

NCT04449926 - BCG and Plasma Amyloid in Non-Demented Adults | Biotech Hunter | Biotech Hunter